Considering Predictive Oncology’s ongoing process to evaluate strategic alternatives, the Company has elected not to host an investor conference call this quarter. Predictive plans to host a corporate ...

Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive ...

President and CEO: Jake Allen - Goldman Sachs: Sung Ji Nam - Scotiabank: Kyle Mikson - Canaccord Genuity: Puneet Souda - ...

Innovative R&D: Pioneering Tumor Microenvironment Typing Recognized for its pioneering work in R&D, BostonGene's Tumor Microenvironment (TME) Typing represents a breakthrough in oncology ...

From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

These miniature immune system models -- known as human immune organoids -- mimic the real-life environment where immune cells learn to recognize and attack harmful invaders and respond to vaccines.

Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.